Costs and outcomes over 36 years of patients with phenylketonuria who do and do not remain on a phenylalanine-restricted diet.

Guest, J F; Bai, J J; Taylor, R R; Sladkevicius, E; Lee, P J; Lachmann, R H

Guest, J F; Bai, J J; Taylor, R R; Sladkevicius, E; Lee, P J; Lachmann, R H.

Affiliation

Guest JF; Catalyst Health Economics Consultants, Northwood, UK School of Biomedical Sciences, King's College, London, UK. julian.guest@catalyst-health.co.uk

J Intellect Disabil Res ; 57(6): 567-79, 2013 Jun.

Article in En | MEDLINE | ID: mdl-22563770

Subject(s)

Health Care Costs/statistics & numerical data; Models, Econometric; Patient Compliance/statistics & numerical data; Phenylketonurias/diet therapy; Phenylketonurias/economics; Adolescent; Adult; Budgets/statistics & numerical data; Comorbidity; Cost-Benefit Analysis; Female; Health Resources/economics; Health Resources/statistics & numerical data; Humans; Incidence; Male; Outcome Assessment, Health Care; Phenylalanine; Phenylketonurias/epidemiology; Retrospective Studies; State Medicine/economics; United Kingdom/epidemiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylketonurias / Patient Compliance / Models, Econometric / Health Care Costs Type of study: Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Country/Region as subject: Europa Language: En Journal: J Intellect Disabil Res Journal subject: TRANSTORNOS MENTAIS Year: 2013 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google